The current COVID-19 pandemic has raised interest in whether there are changes in either the role or safety of ultrasound enhancing agents (UEAs) in echocardiography. This Webinar from experts in the practice of contrast echocardiography will address:
- The impact of UEAs in patients with known or suspected COVID-19.
- Modifications to standard protocols for performing contrast ultrasound on patients who are in high-risk isolation settings.
- Safety of UEAs in patients who are critically ill or who are known to have COVID-19.
|In Cooperation with|